GB0911486D0 - Modified cells and methods of monitoring their viability - Google Patents

Modified cells and methods of monitoring their viability

Info

Publication number
GB0911486D0
GB0911486D0 GBGB0911486.9A GB0911486A GB0911486D0 GB 0911486 D0 GB0911486 D0 GB 0911486D0 GB 0911486 A GB0911486 A GB 0911486A GB 0911486 D0 GB0911486 D0 GB 0911486D0
Authority
GB
United Kingdom
Prior art keywords
viability
monitoring
methods
modified cells
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB0911486.9A
Other versions
GB2461398A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Greater Glasgow Health Board
Original Assignee
Greater Glasgow Health Board
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Greater Glasgow Health Board filed Critical Greater Glasgow Health Board
Publication of GB0911486D0 publication Critical patent/GB0911486D0/en
Publication of GB2461398A publication Critical patent/GB2461398A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1896—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes not provided for elsewhere, e.g. cells, viruses, ghosts, red blood cells, virus capsides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/795—Porphyrin- or corrin-ring-containing peptides
    • C07K14/805—Haemoglobins; Myoglobins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
GB0911486A 2008-07-03 2009-07-02 Globin MRI reporter genes Withdrawn GB2461398A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0812191.5A GB0812191D0 (en) 2008-07-03 2008-07-03 Modified cells and methods of monitoring their viability

Publications (2)

Publication Number Publication Date
GB0911486D0 true GB0911486D0 (en) 2009-08-12
GB2461398A GB2461398A (en) 2010-01-06

Family

ID=39717914

Family Applications (2)

Application Number Title Priority Date Filing Date
GBGB0812191.5A Ceased GB0812191D0 (en) 2008-07-03 2008-07-03 Modified cells and methods of monitoring their viability
GB0911486A Withdrawn GB2461398A (en) 2008-07-03 2009-07-02 Globin MRI reporter genes

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GBGB0812191.5A Ceased GB0812191D0 (en) 2008-07-03 2008-07-03 Modified cells and methods of monitoring their viability

Country Status (2)

Country Link
GB (2) GB0812191D0 (en)
WO (1) WO2010001175A1 (en)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001097678A2 (en) * 2000-06-22 2001-12-27 Henry Ford Health System Imaging and targeting tumors using sickle cells
EP2359868B1 (en) * 2001-06-29 2016-05-04 Sloan-Kettering Institute For Cancer Research Vector encoding human globulin gene and use thereof in treatment of hemoglobinopathies
EP1487499B1 (en) * 2002-03-07 2009-06-10 Carnegie-Mellon University Contrast agents for magnetic resonance imaging and methods related thereto
ES2348868T3 (en) * 2002-12-13 2010-12-16 Genetix Pharmaceuticals Inc. THERAPEUTIC RETROVIRAL VECTORS FOR GENE THERAPY.
WO2005097208A2 (en) * 2004-03-26 2005-10-20 University Of Florida Research Foundation, Inc. Tissue oxygenation measurements
ATE519777T1 (en) * 2006-06-08 2011-08-15 Multi Magnetics Inc MAGNETOSOME GENE EXPRESSION IN EUKARYOTIC CELLS

Also Published As

Publication number Publication date
GB2461398A (en) 2010-01-06
GB0812191D0 (en) 2008-08-13
WO2010001175A1 (en) 2010-01-07

Similar Documents

Publication Publication Date Title
IL272848B (en) Methods for reprogramming cells and uses thereof
IL267138A (en) Improved cell composition and methods of making the same
PL3323883T3 (en) Defined cell culturing surfaces and methods of use
EG26164A (en) Electrolytic cell and method of use thereof
SG2014014484A (en) Electrolytic cell and method of use thereof
EG27167A (en) Microemulsifiers and methods of making and using same
SI2132562T1 (en) Methods of evaluating cells and cell cultures
EP2294406A4 (en) Methods and instrumentation for during-synthesis monitoring of polymer functional evolution
GB0823074D0 (en) Design and method of assembly of cdi cells
IL209754A0 (en) Diazacarbazoles and methods of use
EP2553115A4 (en) Methods for culturing and analyzing cells
GB2460552B (en) Stem cell culture media and methods
SG10201405455UA (en) Cells and methods for obtaining them
IL209548A0 (en) Diazacarbazoles and methods of use
GB0911331D0 (en) Characterising properties or behaviour of biological cells
GB0812789D0 (en) Materials and methods for cell growth
EP2576809A4 (en) Yeast concentration and viability measurement
GB201113641D0 (en) Cell culture support and cell culture method
GB201002469D0 (en) Parthenote-derived stem cells and methods of making and using them
PL2486641T3 (en) BATTERY SYSTEM AND METHOD OF BALANCING THE BATTERY CELLS OF THE BATTERY SYSTEM
PL2318020T3 (en) Immunosuppressive blood cells and methods of producing same
EP2121042A4 (en) Compounds and methods for detection of cells
GB0911486D0 (en) Modified cells and methods of monitoring their viability
EP2334693A4 (en) Methods of long-term culture of eukaryotic cells and uses thereof
EP2318570A4 (en) Electrolytic cell and related methods of making and use

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)